A recent study conducted at Hull University Teaching Hospitals NHS Trust (HUTH) showed a significant 50% decrease in emergency room attendances and admissions for patients with chronic obstructive pulmonary disease (COPD).
COPD is a chronic lung disease affecting over 1.7 million people in the UK, leading to a high rate of hospital admissions.
The Dynamic Rose study, funded by the Small Business Research Initiative, took place from December 2022 to March 2024 and involved over 100 COPD patients from HUTH.
Initial results revealed a remarkable reduction in hospital admissions of more than 50% within the first month of implementing a digital self-management service provided by Lenus Health, with a sustained 45% decrease after three months compared to previous data.
According to Prof. Michael Crooks, a respiratory consultant at HUTH, this study shows promising results in reducing COPD exacerbations, improving patients’ quality of life, and saving valuable hospital resources.
Patients were equipped with Lenus Treat, COPD service for symptom monitoring, self-management, and communication with clinicians. The digital support service proved to be both more effective and cost-efficient compared to standard care.
In Hull, COPD emergency admissions are significantly higher than the national average, highlighting the importance of innovative digital healthcare solutions in managing this condition.
Lenus Health’s collaboration with HUTH mirrors previous successful outcomes in Glasgow, showcasing the potential of digital tools in enhancing patient care and reducing hospital admissions.
The study aligns with the National Institute for Health and Care Excellence draft guidance on digital supported self-management of COPD, emphasizing the growing importance of digital healthcare solutions in improving patient outcomes.
